Application Nr Approved Date Route Status External Links
BLA103836 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Actimmune Is Indicated For Reducing The Frequency And Severity Of Serious Infections Associated With Chronic Granulomatous Disease (Cgd). Actimmune Is Indicated For Delaying Time To Disease Progression In Patients With Severe, Malignant Osteopetrosis (Smo). Actimmune Is An Interferon Gamma Indicated For: Reducing The Frequency And Severity Of Serious Infections Associated With Chronic Granulomatous Disease (Cgd) ( 1 ) Delaying Time To Disease Progression In Patients With Severe, Malignant Osteopetrosis (Smo) ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Interferon Gamma-1b

Comments